Tue, September 8, 2020
Fri, September 4, 2020
Thu, September 3, 2020

Robert Hazlett Maintained (AKBA) at Strong Buy with Decreased Target to $6 on, Sep 4th, 2020

Robert Hazlett of BTIG, Maintained "Akebia Therapeutics, Inc." (AKBA) at Strong Buy with Decreased Target from $26 to $6 on, Sep 4th, 2020.

Robert has made no other calls on AKBA in the last 4 months.



There are 3 other peers that have a rating on AKBA. Out of the 3 peers that are also analyzing AKBA, 0 agree with Robert's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Robert


  • Difei Yang of "Mizuho" Maintained at Strong Buy with Increased Target to $17 on, Wednesday, May 6th, 2020
  • Eric Joseph of "JP Morgan" Maintained at Buy with Increased Target to $18 on, Wednesday, May 6th, 2020
  • Chad Messer of "Needham" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 5th, 2020